Sumer Varlik Yonetim A.S. (IST:SMRVA)
Turkey · Delayed Price · Currency is TRY 246.00
+1.30 (0.53%)
At close: Aug 13, 2025, 6:00 PM GMT+3
CTI BioPharma Revenue
Sumer Varlik Yonetim A.S. had revenue of 594.82M TRY in the quarter ending March 31, 2025, a decrease of -10.83%. This brings the company's revenue in the last twelve months to 1.61B, up 5.14% year-over-year. In the year 2024, Sumer Varlik Yonetim A.S. had annual revenue of 1.68B with 57.31% growth.
Revenue (ttm)
1.61B
Revenue Growth
+5.14%
P/S Ratio
18.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.68B | 613.37M | 57.31% |
| Dec 31, 2023 | 1.07B | 712.99M | 199.56% |
| Dec 31, 2022 | 357.28M | 164.15M | 85.00% |
| Dec 31, 2021 | 193.12M | 92.24M | 91.44% |
| Dec 31, 2020 | 100.88M | 1.88M | 1.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QNB Finansal Kiralama A.S. | 2.45B |
| QNB Bank A.S. | 107.22B |
| Turkiye Garanti Bankasi A.S. | 273.54B |
| Türkiye Is Bankasi A.S. | 282.03B |
| Akbank T.A.S. | 152.90B |
| Türkiye Vakiflar Bankasi Türk Anonim Ortakligi | 187.07B |
| Yapi ve Kredi Bankasi A.S. | 140.08B |
| Destek Finans Faktoring A.S. | 5.71B |